Posts From December, 2018

This study investigates predictors of visual outcomes in patients who underwent vitrectomy for full-thickness macular hole. Source: AAO

• Posted on: Dec 11 2018
• By: Saratoga Opthalmology
• Leave a response

These uveitis papers, published in 2017, were selected by members of the American Uveitis Society for their outstanding teaching value for residents. Source: AAO

• Posted on: Dec 11 2018
• By: Saratoga Opthalmology
• Leave a response

This clinical trial compared pneumatic retinopexy (PnR) and pars plana vitrectomy (PPV) for management of rhegmatogenous retinal detachment (RRD). Source: AAO

• Posted on: Dec 10 2018
• By: Saratoga Opthalmology
• Leave a response

The current study investigates the effect of oral statin therapy on strabismus related to thyroid eye disease. Source: AAO

• Posted on: Dec 7 2018
• By: Saratoga Opthalmology
• Leave a response

This week, the FDA fast tracks a home-based OCT system, late-night screen time resets the circadian clock and a new retinal implant is (literally) out of this world. Source: AAO

• Posted on: Dec 7 2018
• By: Saratoga Opthalmology
• Leave a response

The current study describes the outcomes of globe-preserving surgery combined with high-dose proton beam radiation (PBR) in treating patients with primary adenoid cystic carcinoma of the lacrimal gland. Source: AAO

• Posted on: Dec 6 2018
• By: Saratoga Opthalmology
• Leave a response

Ocular Therapeutix announced FDA clearance of their dexamethasone punctum plug (Dextenza) for managing ocular pain after cataract surgery. The implant is the first intracanalicular drug delivery device. Source: AAO

• Posted on: Dec 6 2018
• By: Saratoga Opthalmology
• Leave a response

This prospective study evaluated whether ultrasonographic optic nerve sheath diameter (ONSD) measurements could be used to monitor intracranial pressure (ICP). Source: AAO

• Posted on: Dec 5 2018
• By: Saratoga Opthalmology
• Leave a response

Investigators examined the efficacy of tocilizumab in patients with moderate-to-severe corticosteroid-resistant Graves orbitopathy (GO). Source: AAO

• Posted on: Dec 4 2018
• By: Saratoga Opthalmology
• Leave a response

This study assessed the safety and feasibility of delivering retinal pigment epithelial (RPE) cells derived from a human embryo into the subretinal space of patients with macular degeneration. Source: AAO

• Posted on: Dec 3 2018
• By: Saratoga Opthalmology
• Leave a response